Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Buchsbaum

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Bioconjugate Chemistry|March 20, 2003
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug deliveryAhmad Safavy, James A Bonner, Harlan W Waksal, et al.
Gynecologic Oncology|February 17, 2007
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Medcomm|October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RASAntonio B Ward, Adam B Keeton, Xi Chen, et al.
Molecular Imaging and Biology|April 13, 2010
DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapyHyunki Kim, Karri D Folks, Lingling Guo, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Jump-starting the T cell response in established tumorsTyler R McCaw, Mingyong Liu, Christopher D Scharer, et al.
Cancer Biology & Therapy|April 26, 2007
ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinibAndrey Frolov, Kyle Schuller, Ching-Wei D Tzeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effectsCarmelo Blanquicett, M Wasif Saif, Donald J Buchsbaum, et al.
Vaccine|July 5, 2008
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effectsChih Wen Tseng, Archana Monie, Cornelia Trimble, et al.
Molecular Imaging|April 19, 2011
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imagingHyunki Kim, Karri D Folks, Lingling Guo, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Bioconjugate Chemistry|March 20, 2003
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug deliveryAhmad Safavy, James A Bonner, Harlan W Waksal, et al.
Gynecologic Oncology|February 17, 2007
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Medcomm|October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RASAntonio B Ward, Adam B Keeton, Xi Chen, et al.
Molecular Imaging and Biology|April 13, 2010
DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapyHyunki Kim, Karri D Folks, Lingling Guo, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Jump-starting the T cell response in established tumorsTyler R McCaw, Mingyong Liu, Christopher D Scharer, et al.
Cancer Biology & Therapy|April 26, 2007
ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinibAndrey Frolov, Kyle Schuller, Ching-Wei D Tzeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effectsCarmelo Blanquicett, M Wasif Saif, Donald J Buchsbaum, et al.
Vaccine|July 5, 2008
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effectsChih Wen Tseng, Archana Monie, Cornelia Trimble, et al.
Molecular Imaging|April 19, 2011
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imagingHyunki Kim, Karri D Folks, Lingling Guo, et al.
Pageof 16